CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Cash flows provided by operating activities:
Net income	$ 38,537	$ 5,895
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	1,629	$ 1,103
Amortization of intangible assets	42
Amortization of premiums on available-for-sale marketable securities	35
Stock-based compensation related to employees and non-employees consultants stock options	4,057	$ 780
Realized gains on cash flow hedges	$ (2)
Financial income, net related to term loan		$ (656)
Remeasurement of warrants to purchase preferred and common stock		265
Changes in assets and liabilities:
Inventories	$ (13,452)	(22,128)
Prepaid expenses and other accounts receivable	6,504	(10,671)
Trade receivables, net	(11,268)	$ (5,919)
Deferred tax assets, net	(6,527)
Trade payables	(18,701)	$ 33,429
Employees and payroll accruals	6,073	361
Warranty obligations	9,015	6,116
Deferred revenues	3,446	1,694
Accrued expenses and other accounts payable	(273)	$ (860)
Lease incentive obligation	(65)
Net cash provided by operating activities	19,050	$ 9,409
Cash flows used in investing activities:
Investment in available-for-sale marketable securities	(52,860)
Purchase of property and equipment	(5,636)	$ (3,133)
Purchase of intangible assets	(800)
Decrease (increase) in restricted cash	222	$ (1,807)
Decrease (increase) in short and long-term lease deposits	37	(31)
Net cash used in investing activities	$ (59,037)	(4,971)
Cash flows from financing activities:
Proceeds from short-term bank loans		6,000
Repayments of short-term loan		(19,326)
Repayments of term loan		(1,578)
Proceeds from issuance of Series E Convertible Preferred stock		24,837
Issuance costs		(292)
Proceeds from exercise of employee stock options	$ 1,472	16
Net cash provided by financing activities	1,472	9,657
Increase (decrease) in cash and cash equivalents	(38,515)	14,095
Cash and cash equivalents at the beginning of the period	144,750	9,754
Erosion due to exchange rate differences	(85)	(75)
Cash and cash equivalents at the end of the period	$ 106,150	23,774
Supplemental disclosure of non-cash financing activities:
Deferred issuance costs related to IPO		1,542
Issuance expenses not paid in cash		$ 125
Purchase of property and equipment not paid in cash	$ 475